期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
CRISPR accelerates the cancer drug discovery
1
作者 RUYU YAN JUNJIE WANG +1 位作者 MINXIA LIU KECHENG ZHOU 《BIOCELL》 SCIE 2022年第10期2159-2165,共7页
Emerging cohorts and basic studies have associated certain genetic modifications in cancer patients,such as gene mutation,amplification,or deletion,with the overall survival prognosis,underscoring patients’genetic ba... Emerging cohorts and basic studies have associated certain genetic modifications in cancer patients,such as gene mutation,amplification,or deletion,with the overall survival prognosis,underscoring patients’genetic background may directly regulate drug sensitivity/resistance during chemotherapies.Understanding the molecular mechanism underpinning drug sensitivity/resistance and further uncovering the effective drugs have been the major ambition in the cancer drug discovery.The emergence and popularity of CRISPR/Cas9 technology have reformed the entire life science research,providing a precise and simplified genome editing tool with unlimited editing possibilities.Furthermore,it presents a powerful tool in cancer drug discovery,which hopefully facilitates us with a rapid and reliable manner in developing novel therapies and understanding the molecular mechanisms of drug sensitivity/resistance.Herein,we summarized the application of CRISPR/Cas9 in drug screening,with the focus on CRISPR/Cas9 mediated gene knockout,gene knock-in,as well as transcriptional modification.Additionally,this review provides the concerns,cautions,and ethnic considerations that need to be taken when applying CRISPR in the drug discovery. 展开更多
关键词 CRISPR/Cas9 Cancer drug discovery drug sensitivity/resistance Novel cancer therapies
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部